Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to characterize organ dysfunction change in acute necrotizing pancreatitis patients with sepsis after open necrosectomy.


Clinical Trial Description

Before surgery, study participants will be asked questions about age, gender, education level, etc. Study participants will also be questioned regarding pancreatic symptoms, as measured on the patient-Reported Outcome Scale in Acute Pancreatitis (including, pain, abdominal distention, eating, bowel movements, nausea and vomiting, thirst, and weakness). Organ dysfunction was defined according to the sequential organ failure assessment (SOFA) score. The SOFA score will be measured at preoperative (T1), postoperative day 1 (T2), postoperative day 3 (T3), postoperative day 7, or at hospital discharge, whichever comes first (T4). Following discharge from the hospital, study participants will be contacted at 1 month, 3 months, 6 months, and 1 year after surgery, and asked to complete a survey about their pancreatic symptoms and survival status after surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06380842
Study type Observational
Source West China Hospital
Contact Chunling Jiang, PhD
Phone 18980601096
Email jiangchunling@scu.edu.cn
Status Not yet recruiting
Phase
Start date April 15, 2024
Completion date December 30, 2026

See also
  Status Clinical Trial Phase
Completed NCT04986943 - ABTHERA ADVANCEā„¢ Use Without Wittman Patch
Completed NCT03694210 - EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial N/A
Completed NCT01815489 - Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Not yet recruiting NCT04963868 - Timing of Transmural Stent Removal in Necrotizing Pancreatitis N/A
Withdrawn NCT02564965 - Endoscopic Large Caliber Drainage vs. Complete Necrosectomy for Treatment of Walled-off Pancreatic Necrosis N/A
Completed NCT03115918 - Pancreatic Duct Stent for Acute Necrotizing Pancreatitis N/A